[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353232-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353232-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","computational-fluid-dynamics-simulations-to-inform-cancer-therapeutics","Computational Fluid Dynamics Simulations to Inform Cancer Therapeutics","","Cancer therapies such as chemotherapy, radiopharmaceutical therapy, and transarterial embolization depend on effective delivery of drugs or radiation through the bloodstream. Because drug and particle transport occur across multiple spatial scales, optimizing treatment requires understanding how particles of different sizes and drugs move through blood and tissue. Computational fluid dynamics (CFD) simulates blood flow and drug transport by solving biologically realistic governing equations. This review evaluates CFD for radioembolization, tumor perfusion, and organ-on-a-chip systems, and discusses key challenges and integration opportunities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/computational-fluid-dynamics-simulations-to-inform-cancer-therapeutics/353232/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/computational-fluid-dynamics-simulations-to-inform-cancer-therapeutics/353232.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is understanding drug and particle transport critical for cancer therapeutics?","Question",{"text":63,"@type":64},"Because therapeutic efficacy and toxicity depend on how drugs and particles are transported through blood and tissue, and these processes occur across multiple scales.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does computational fluid dynamics (CFD) support cancer therapy research and planning?",{"text":68,"@type":64},"CFD simulates blood flow and particle transport by solving governing equations such as the Navier–Stokes framework with biologically relevant constraints and boundary conditions.",{"name":70,"@type":61,"acceptedAnswer":71},"In what applications does the review highlight CFD for cancer treatment?",{"text":72,"@type":64},"The review focuses on transarterial embolization, tumor perfusion modeling, and organ-on-a-chip systems, including predicting microsphere transport and dose distribution in radioembolization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353232,1790218846,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Annu Rev Biomed Eng. Author manuscript; available in PMC 2026 July 06. |\n| --- | --- |\n\nPublished in final edited form as:  \nAnnu Rev Biomed Eng. 2026 May ; 28(1): 515–538. doi:10.1146/annurev-bioeng-110824-021423 .  \nComputational Fluid Dynamics Simulations to Inform Cancer Therapeutics  \nEmilie Roncali 1,2 , Amirtahà Taebi3  \n1 Department of Biomedical Engineering, University of California, Davis, California, USA  \n2 Department of Radiology, UC Davis Health, Davis, California, USA  \n3 Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA  \nAbstract  \nCancer therapies such as chemotherapy, radiopharmaceutical therapy, and transarterial embolization rely on effective drug or radiation delivery through the bloodstream. Understanding how various drugs and particles, which form and size span multiple scales, are transported through blood and tissue is essential for optimizing treatment. Computational fluid dynamics (CFD) is a powerful tool to simulate blood flow and drug transport, solving flow governing equations under biologically realistic conditions. This review explores CFD applications in cancer therapy, focusing on transarterial embolization, tumor perfusion, and organ-on-a-chip systems. In radioembolization, CFD can predict microsphere transport and dose distribution to spare vital functions. Tumor perfusion modeling and organ-on-a-chip systems benefit from CFD by replicating vascular dynamics and drug dispersion. Despite its versatility and established mechanical principles, CFD faces challenges, including the need for patient-specific data, computational demands, and multiscale modeling. This review highlights opportunities for integrating CFD with imaging modalities and artificial intelligence tools to overcome these barriers and advance personalized cancer treatment.  \nKeywords  \ncomputational fluid dynamics; cancer therapeutics; modeling; simulation; fluid flow; particle transport; organ-on-a-chip  \nThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NCND 4.0), which permits any noncommercial use, sharing, distribution, and reproduction in any medium or format, provided the original author(s) and source are credited; this license does not permit sharing adapted material derived from this article or parts of it. Images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise; see credit lines for license information.  \n[eroncali@ucdavis.edu](eroncali@ucdavis.edu) .  \nDISCLOSURE STATEMENT  \nThe authors are not aware of any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this review.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nRoncali and Taebi Page 2  \n1. INTRODUCTION  \n1.1. Background  \nCancer therapeutics such as chemotherapy, immunotherapy, radiopharmaceutical therapy, or embolization techniques inherently involve drug delivery via blood (1–5). Delivery can take many forms: venous, arterial, systemic, loco-regional, or intratumoral, thus involving different mechanisms of transport in blood and vectors (e.g., molecules, particles, vesicles, micelles) (6, 7). Delivery and transport in blood and tissue are essential determinants of therapeutic efficacy and toxicity, thus requiring thorough understanding of underlying mechanisms, careful treatment planning, and controlled environmental conditions. Studying and optimizing transport and delivery are of great interest to both academia and pharmaceutical companies, which need precise and accurate tools to do so. Computational fluid dynamics (CFD) is one such discipline that can inform about drug delivery, hemodynamics, and drug transport (8) .  \nCFD applied to biofluids simulates how fluids such as ","cbCaihz6fTgjTKEe","https://ap.wps.com/l/cbCaihz6fTgjTKEe","pdf",1756061,28,"English","# Abstract\n# Keywords\n# Introduction\n## Background\n## CFD for Transarterial Embolization\n## Radioembolization","[{\"question\":\"Why is understanding drug and particle transport critical for cancer therapeutics?\",\"answer\":\"Because therapeutic efficacy and toxicity depend on how drugs and particles are transported through blood and tissue, and these processes occur across multiple scales.\"},{\"question\":\"How does computational fluid dynamics (CFD) support cancer therapy research and planning?\",\"answer\":\"CFD simulates blood flow and particle transport by solving governing equations such as the Navier–Stokes framework with biologically relevant constraints and boundary conditions.\"},{\"question\":\"In what applications does the review highlight CFD for cancer treatment?\",\"answer\":\"The review focuses on transarterial embolization, tumor perfusion modeling, and organ-on-a-chip systems, including predicting microsphere transport and dose distribution in radioembolization.\"}]","Computational Fluid Dynamics Simulations to Inform Cancer Therapeutics | PDF",1790103736,71,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0a4788f24a1d44a986216d23fd330fe.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f687ae8f880cd41580861cf34872b53.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/252e28851c8ef7d32406c5babad91506.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43c159c52d28c26bc54c8d9d44c89237.webp",980,1268]